文献速递消化、代谢与肾脏急症重症综合管理与镇静镇痛

KLF6通过抑制miR-223-3p促进NLRP3介导的肾小管上皮细胞焦亡加重脓毒症急性肾损伤

KLF6 Promotes Pyroptosis of Renal Tubular Epithelial Cells in Septic Acute Kidney Injury.
PubMed 文献 · Shock · 2022-01-01
一句话结论基础研究提示KLF6/miR-223-3p/NLRP3轴促进肾小管上皮细胞焦亡,敲低KLF6可减轻SAKI小鼠氧化应激和焦亡。

该研究为动物与细胞基础实验,建立盲肠结扎穿刺SAKI小鼠模型及LPS处理TCMK-1细胞模型。结果发现KLF6在SAKI中高表达,敲低KLF6可减轻氧化应激和焦亡。机制上KLF6结合miR-223-3p启动子抑制其表达,进而上调NLRP3,激活NLRP3/Caspase-1/IL-1β通路;下调miR-223-3p可加重氧化应激和焦亡。目前仅为机制探索,尚无临床干预数据。

要点

  • 研究为SAKI小鼠(盲肠结扎穿刺)及LPS处理TCMK-1细胞基础实验,非临床研究,不能直接推导床旁治疗推荐。
  • KLF6在SAKI中高表达;敲低KLF6可减轻SAKI小鼠和LPS处理TCMK-1细胞的氧化应激与焦亡。
  • 机制:KLF6结合miR-223-3p启动子抑制miR-223-3p,上调NLRP3并激活NLRP3/Caspase-1/IL-1β通路。
  • 下调miR-223-3p可激活NLRP3/Caspase-1/IL-1β通路,加重氧化应激和焦亡。
  • 尚无KLF6或miR-223-3p作为SAKI诊断标志物或治疗靶点的临床验证数据,原文未提供。

适用人群与场景

  • 基础研究层面:盲肠结扎穿刺建立的SAKI小鼠模型及LPS处理的TCMK-1肾小管上皮细胞;原文未涉及临床患者纳入或排除标准。

诊断标准与关键阈值

  • 原文未提及

处置流程与药物剂量

  • 原文未提及

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 研究类型:基础实验(动物模型+细胞模型),非临床研究;样本量、中心数原文未提及。
  • 模型:SAKI小鼠采用盲肠结扎穿刺建立;体外细胞模型采用LPS处理TCMK-1细胞。
  • 干预:SAKI小鼠和LPS处理TCMK-1细胞给予KLF6 siRNA敲低KLF6;另设rescue实验验证miR-223-3p作用。
  • 机制结果:KLF6通过结合miR-223-3p启动子抑制miR-223-3p并促进NLRP3;下调miR-223-3p激活NLRP3/Caspase-1/IL-1β通路,加重氧化应激和焦亡。
  • 不良事件:原文未提及。

证据类型、等级与局限

  • 证据类型:基础研究(动物实验与细胞实验),非RCT、队列或系统评价;原文未给出证据等级或推荐强度。
  • 局限:仅为临床前机制研究,无临床样本验证,无临床结局数据;样本量、盲法、重复次数等原文未提及。

对床旁实践的改变

  • 本文为基础机制研究,原文未提供可改变急诊/ICU床旁实践的具体临床干预、药物剂量或监测阈值。
  • KLF6/miR-223-3p/NLRP3轴目前仅为SAKI发病机制假说,不能作为临床诊断标志物或治疗靶点常规使用;适用与不适用人群原文未提及。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

Septic acute kidney injury (SAKI) represents a clinical challenge with high morbidity and mortality. The current study aimed to analyze the effects and molecular mechanism of Krüppel-like factor 6 (KLF6) on SAKI. First, SAKI mouse models were established by cecum ligation and puncture, while in vivo cell models were established using lipopolysaccharide (LPS). RT-qPCR assay was subsequently performed to detect the levels of KLF6 mRNA. SAKI mice and LPS-treated TCMK-1 cells were further treated with KLF6 siRNA. Afterward, HE staining, PAS staining, Western blot assay, and ELISA were adopted to ascertain the effects of KLF6 in pyroptosis. The binding relationships between KLF6 and miR-223-3p promoter /miR-223-3p and NLRP3 were analyzed with the help of CHIP and dual-luciferase reporter assays. RT-qPCR was adopted to determine the expression patterns of miR-223-3p and NLRP3. Lastly, a rescue experiment was designed to confirm the role of miR-223-3p. It was found that KLF6 was highly expressed in SAKI, whereas knockdown of KLF6 alleviated oxidative stress (OS) and pyroptosis in SAKI mice and LPS-treated TCMK-1 cells. Mechanistic results confirmed that KLF6 inhibited miR-223-3p via binding to the miR-223-3p promoter and promoted NLRP3. On the other hand, downregulation of miR-223-3p activated the NLRP3/Caspase-1/IL-1β pathway and aggravated OS and pyroptosis. Overall, our findings indicated that KLF6 inhibited miR-223-3p via binding to the miR-223-3p promoter and promoted NLRP3, and activated the NLRP3/Caspase-1/IL-1β pathway, thereby aggravating pyroptosis and SAKI.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Gao M, Li H, Liu Q, et al. KLF6 Promotes Pyroptosis of Renal Tubular Epithelial Cells in Septic Acute Kidney Injury. Shock. 2022. PMID: 34710881. doi:10.1097/SHK.0000000000001881

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。